pu.1 (spi1) Search Results


scientific rrid hs01062469 m1 spi1 pu 1  (Thermo Fisher)
88
Thermo Fisher scientific rrid hs01062469 m1 spi1 pu 1
Scientific Rrid Hs01062469 M1 Spi1 Pu 1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scientific rrid hs01062469 m1 spi1 pu 1/product/Thermo Fisher
Average 88 stars, based on 1 article reviews
scientific rrid hs01062469 m1 spi1 pu 1 - by Bioz Stars, 2026-03
88/100 stars
  Buy from Supplier
antibodies against spi1  (Proteintech)
93
Proteintech antibodies against spi1
Fig. 1 <t>SPI1</t> expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001
Antibodies Against Spi1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against spi1/product/Proteintech
Average 93 stars, based on 1 article reviews
antibodies against spi1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
goat serum  (Boster Bio)
90
Boster Bio goat serum
Fig. 1 <t>SPI1</t> expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001
Goat Serum, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat serum/product/Boster Bio
Average 90 stars, based on 1 article reviews
goat serum - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mouse pu 1  (OriGene)
93
OriGene mouse pu 1
Fig. 1 <t>SPI1</t> expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001
Mouse Pu 1, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse pu 1/product/OriGene
Average 93 stars, based on 1 article reviews
mouse pu 1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
spi1  (OriGene)
90
OriGene spi1
Fig. 1 <t>SPI1</t> expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001
Spi1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spi1/product/OriGene
Average 90 stars, based on 1 article reviews
spi1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human cdna clones  (OriGene)
90
OriGene human cdna clones
Fig. 1 <t>SPI1</t> expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001
Human Cdna Clones, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cdna clones/product/OriGene
Average 90 stars, based on 1 article reviews
human cdna clones - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
plenti c myc ddkp2a puro  (OriGene)
91
OriGene plenti c myc ddkp2a puro
Fig. 1 <t>SPI1</t> expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001
Plenti C Myc Ddkp2a Puro, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plenti c myc ddkp2a puro/product/OriGene
Average 91 stars, based on 1 article reviews
plenti c myc ddkp2a puro - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier
antibodies directed against the amino-terminal domain of pu.1/spi-1  (Institut Curie)
90
Institut Curie antibodies directed against the amino-terminal domain of pu.1/spi-1
Fig. 1 <t>SPI1</t> expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001
Antibodies Directed Against The Amino Terminal Domain Of Pu.1/Spi 1, supplied by Institut Curie, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies directed against the amino-terminal domain of pu.1/spi-1/product/Institut Curie
Average 90 stars, based on 1 article reviews
antibodies directed against the amino-terminal domain of pu.1/spi-1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
transcription factors pu.1 (spi1)  (SusTech GmbH)
90
SusTech GmbH transcription factors pu.1 (spi1)
Fig. 1 <t>SPI1</t> expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001
Transcription Factors Pu.1 (Spi1), supplied by SusTech GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transcription factors pu.1 (spi1)/product/SusTech GmbH
Average 90 stars, based on 1 article reviews
transcription factors pu.1 (spi1) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 1 SPI1 expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001

Journal: Discover. Oncology

Article Title: SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

doi: 10.1007/s12672-022-00592-0

Figure Lengend Snippet: Fig. 1 SPI1 expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001

Article Snippet: Antibodies against SPI1 (66618–2-lg; Proteintech) andβ-Tubulin (BE0025; EASYBIO) were used.

Techniques: Expressing

Fig. 2 Relationship between SPI1 expression and clinicopathological parameters in ccRCC. a Clinicopathological parameters correlated with SPI1 expression. b–e High SPI1 expression level was associated with high Furman grade (b), T stage (c), positive nodal status (d), and metas- tasis status (e). ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001

Journal: Discover. Oncology

Article Title: SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

doi: 10.1007/s12672-022-00592-0

Figure Lengend Snippet: Fig. 2 Relationship between SPI1 expression and clinicopathological parameters in ccRCC. a Clinicopathological parameters correlated with SPI1 expression. b–e High SPI1 expression level was associated with high Furman grade (b), T stage (c), positive nodal status (d), and metas- tasis status (e). ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001

Article Snippet: Antibodies against SPI1 (66618–2-lg; Proteintech) andβ-Tubulin (BE0025; EASYBIO) were used.

Techniques: Expressing

Fig. 3 Prognostic value of SPI1. a, b High SPI1 expression level predicted poor OS (a) and PFS b in ccRCC. c, d OS (c) and PFS (d) predictions of patients with ccRCC at five years after surgery are shown in nomograms. e, f Calibration plots of the nomograms for the prediction of five- year OS e and PFS f. ccRCC clear cell renal cell carcinoma; OS overall survival; PFS progression-free survival

Journal: Discover. Oncology

Article Title: SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

doi: 10.1007/s12672-022-00592-0

Figure Lengend Snippet: Fig. 3 Prognostic value of SPI1. a, b High SPI1 expression level predicted poor OS (a) and PFS b in ccRCC. c, d OS (c) and PFS (d) predictions of patients with ccRCC at five years after surgery are shown in nomograms. e, f Calibration plots of the nomograms for the prediction of five- year OS e and PFS f. ccRCC clear cell renal cell carcinoma; OS overall survival; PFS progression-free survival

Article Snippet: Antibodies against SPI1 (66618–2-lg; Proteintech) andβ-Tubulin (BE0025; EASYBIO) were used.

Techniques: Expressing

Fig. 4 Relationship between SPI1 expression and CD68 + macrophages, CD4 + T cells, and CD8 + T cells infiltration. a SPI1 expression correlated posi- tively with CD68 + macrophages, CD4 + T cells, and CD8 + T cells infiltration in our cohort. b SPI1, CD68 + , CD8 + , and CD4 + expression levels in the same patients are shown by IHC. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001; IHC, immunohistochemistry

Journal: Discover. Oncology

Article Title: SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

doi: 10.1007/s12672-022-00592-0

Figure Lengend Snippet: Fig. 4 Relationship between SPI1 expression and CD68 + macrophages, CD4 + T cells, and CD8 + T cells infiltration. a SPI1 expression correlated posi- tively with CD68 + macrophages, CD4 + T cells, and CD8 + T cells infiltration in our cohort. b SPI1, CD68 + , CD8 + , and CD4 + expression levels in the same patients are shown by IHC. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001; IHC, immunohistochemistry

Article Snippet: Antibodies against SPI1 (66618–2-lg; Proteintech) andβ-Tubulin (BE0025; EASYBIO) were used.

Techniques: Expressing, Immunohistochemistry

Fig. 5 Relationship between SPI1 expression and immunotherapy efficacy. a SPI1 expression in three responders receiving immunotherapy. b SPI1 expression in four non-responders receiving immunotherapy. Responders included patients with complete disease and partial dis- ease, and non-responders included patients with progressive disease and stable disease

Journal: Discover. Oncology

Article Title: SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

doi: 10.1007/s12672-022-00592-0

Figure Lengend Snippet: Fig. 5 Relationship between SPI1 expression and immunotherapy efficacy. a SPI1 expression in three responders receiving immunotherapy. b SPI1 expression in four non-responders receiving immunotherapy. Responders included patients with complete disease and partial dis- ease, and non-responders included patients with progressive disease and stable disease

Article Snippet: Antibodies against SPI1 (66618–2-lg; Proteintech) andβ-Tubulin (BE0025; EASYBIO) were used.

Techniques: Expressing

Fig. 6 Genes coexpressed with SPI1 in KIRC using the LinkedOmics database. a, b The top 50 genes positively and negatively associated with SPI1 shown in the heat maps. Blue represents negatively linked genes and red represents positively linked genes. c, d Gene Ontology annotations c and Kyoto Encyclopedia of Genes and Genomes pathways (d) of SPI1 in KIRC cohort. KIRC, kidney renal clear cell carcinoma

Journal: Discover. Oncology

Article Title: SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

doi: 10.1007/s12672-022-00592-0

Figure Lengend Snippet: Fig. 6 Genes coexpressed with SPI1 in KIRC using the LinkedOmics database. a, b The top 50 genes positively and negatively associated with SPI1 shown in the heat maps. Blue represents negatively linked genes and red represents positively linked genes. c, d Gene Ontology annotations c and Kyoto Encyclopedia of Genes and Genomes pathways (d) of SPI1 in KIRC cohort. KIRC, kidney renal clear cell carcinoma

Article Snippet: Antibodies against SPI1 (66618–2-lg; Proteintech) andβ-Tubulin (BE0025; EASYBIO) were used.

Techniques: